Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.21 -0.11 (-0.12%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025)

Updated

Dianthus Therapeutics' Interest & Investment Income was $3.66 million in Q3 2025, down 17.7% from $4.45 million a year earlier but up 7.5% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025) Analysis & Trends

On a trailing twelve-month basis, Dianthus Therapeutics' Interest & Investment Income was $14.84 million through Sep 30, 2025, down 6.2% year-over-year; for FY2024, it came in at $17.37 million, up 264.5% from FY2023.

  • Interest & Investment Income shows a five-year compound annual growth rate of 22.9% (FY2019 to FY2024).
  • In earlier years, Interest & Investment Income was $4.76 million in FY2023 (+316.1%), $1.15 million in FY2022 (-67.8%), $3.56 million in FY2021 (-5.6%) and $3.77 million in FY2020 (-39.3%).
  • Quarterly Interest & Investment Income has moved between $416,000 (Q3 2022) and $4.71 million (Q2 2024) over five years.
  • Compared with a year earlier, Interest & Investment Income has declined for three straight quarters, with growth averaging 225.5% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q1 2024 (growth of 596.7%); the worst was Q3 2022 (a decline of 49.1%).
  • Per Business Quant data, DNTH's Interest & Investment Income in the three quarters before Q3 2025 was $3.4 million (Q2 2025), $3.79 million (Q1 2025) and $3.99 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Dianthus Therapeutics 3.78 Bn 3.73 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.66 Mn
Jun 30, 2025 3.40 Mn
Mar 31, 2025 3.79 Mn
Dec 31, 2024 3.99 Mn
Sep 30, 2024 4.45 Mn
Jun 30, 2024 4.71 Mn
Mar 31, 2024 4.22 Mn
Dec 31, 2023 2.44 Mn
Sep 30, 2023 1.03 Mn
Jun 30, 2023 687,000.00
Mar 31, 2023 606,000.00
Dec 31, 2022 640,000.00
Sep 30, 2022 416,000.00
Jun 30, 2022 812,000.00
Mar 31, 2022 884,000.00
Dec 31, 2021 848,000.00
Sep 30, 2021 818,000.00
Jun 30, 2021 682,000.00
Mar 31, 2021 1.21 Mn
Dec 31, 2020 897,000.00
API Access

Dianthus Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=DNTH&period=max&api_key=YOUR_API_KEY